Cristin-person-ID: 907886
Person

Line Skute Bråten

  • Stilling:
    Stipendiat
    ved Senter for Psykofarmakologi ved Diakonhjemmet sykehus

Resultater Resultater

What is the Current Clinical Impact of the CYP2CTG Haplotype?

Ingelman-Sundberg, Magnus; Jukic, Marin; Bråten, Line Skute; Kringen, Marianne K.; Molden, Espen. 2023, Clinical Pharmacology and Therapeutics. UUB, DIAKONSYK, OSLOMET, UIO, KIBrev til redaktøren

Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population.

Bråten, Line Skute; Ingelman-Sundberg, Magnus; Jukic, Marin M.; Molden, Espen; Kringen, Marianne K.. 2022, Clinical and Translational Science (CTS). UUB, DIAKONSYK, OSLOMET, UIO, KIVitenskapelig artikkel

A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram.

Bråten, Line Skute; Haslemo, Tore; Jukić, Marin M.; Ivanov, Maxim; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K.. 2021, Clinical Pharmacology and Therapeutics. UUB, DIAKONSYK, OSLOMET, KU, UIO, KIVitenskapelig artikkel

The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O -Desmethylvenlafaxine Concentrations in a Large Patient Cohort.

Kringen, Marianne K.; Bråten, Line Skute; Haslemo, Tore; Molden, Espen. 2020, Journal of Clinical Psychopharmacology. DIAKONSYK, OSLOMET, UIOVitenskapelig artikkel

Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.

Bråten, Line Skute; Haslemo, Tore; Jukic, Marin M.; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K.. 2019, Neuropsychopharmacology. UUB, DIAKONSYK, OSLOMET, UIO, KIVitenskapelig artikkel
1 - 5 av 6 | Neste | Siste »